Table 2. Selection of exams independently of the risk of disease relapse.
| At diagnosis | At follow-up | ||||
| NO | YES | NO | YES | P value | |
| No. (%) | No. (%) | No. (%) | No. (%) | ||
| Blood chemistry tests | 0 | 25 (100.0) | 10 (40.0) | 15 (60.0) | <0.0001 |
| Tumor markers | 3 (12.0) | 22 (88.0) | 5 (20.0) | 20 (80.0) | 0.47 |
| Chest radiograph | 3 (12.0) | 22 (88.0) | 18 (72.0) | 7 (28.0) | <0.0001 |
| Liver ultrasound | 0 | 25 (100.0) | 14 (56.0) | 11 (44.0) | <0.001 |
| Bone scan | 1 (4.2) | 24 (96.0) | 20 (80.0) | 5 (20.0) | <0.0001 |
| Whole-body CT scan | 19 (76.0) | 6 (24.0) | 25 (100.0) | - | 0.01 |
| Whole-body PET/CT scan | 25 (100.0) | 0 | 25 (100.0) | - | - |